The surge in consumption of herbal remedies has been stimulated by several factors, including the notion that all herbal products are safe and effective, consumers becoming more proactive in self-treating, and lack of regulation by the Food and Drug Administration. Although herbal remedies are generally perceived as harmless, reports of hepatotoxicity associated with herbal use are accumulating, suggesting they are not completely innocuous. On the basis of various case reports, the liver injury from herbal remedies has ranged from mild elevations of liver enzymes to fulminant liver failure requiring liver transplantation. Although regulation by the Food and Drug Administration may be part of the solution, increasing public awareness and educating healthcare professionals about the potential dangers of herbal preparations will need to be implemented. This article reviews the hepatotoxicity of herbal remedies as reported in the literature and discusses issues related to regulation of herbal preparations.
Get full access to this article
View all access options for this article.
References
1.
EisenbergDMKesslerRFosterCNorlockFECalkinsDRDelbancoTL. Unconventional medicine in the United States. Prevalence, costs and patterns of use. N Engl J Med.1993;328:246–252.
2.
EisenbergDMDavisRBEttnerSL. Trends in alternate medicine use in the United States, 1990–1997: Results of a follow-up national survey. JAMA.1998;280:1569–1575.
3.
BerkBSChayaCBennerKCFloraKD. Comparison of herbal therapy for liver disease: 1996 versus 1999 [abstract]. Hepatology.1999;30:478A.
4.
SchuppanDJiaJ-DBrinkhausBHahnEG. Herbal products for liver diseases: A therapeutic challenge for the new millennium. Hepatology.1999;30:1099–1104.
5.
KaufmanDWKellyJPRosenbergLAndersonTEMitchellAA. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA.2002;287:337–344.
6.
MarcusDMGrollmanAP. Botanical medicines: The need for new regulations. N Engl J Med.2002;347:2973–2076.
Ang-LeeMKMossJYuanCS. Herbal medicines and perioperative care. JAMA.2001;286:208–216.
9.
Food and Drug Administration. Letter warning health care professionals about kava. Available at: www.fda.gov/med watch/safety/2001/kava.htm. Accessed September 15, 2003.
10.
EisenbergDMKesslerRCVan RompayMI. Perceptions about complementary therapies relative to conventional therapies among adults who use both: Results from a national survey. Ann Intern Med.2001;135:344–351.
11.
KoffRS. Herbal hepatotoxicity: Revisiting a dangerous alternantive. JAMA.1995;273:502.
12.
SteenkampVStewartMZuckermanM. Clinical and analytical aspects of pyrrolizidine alkaloid poisoning caused by South African traditional medicines. Ther Drug Monit.2000; 22:302–306.
13.
LeeWM. Drug-induced hepatotoxicity. N Engl J Med.2003;349:474–485.
14.
SchenkerSMartinRRHoyumpaAM. Antecedent liver disease and drug toxicity. J Hepatol.1999;31:1098–1105.
15.
MohabbatOSrivastavaRNYounosMSSedioGGMerzadAAAramGN. An outbreak of haptic veno-occlusive disease in North-Western Afghanistan. Lancet.1976;2:269–271.
16.
BatemanJChapmanRDSimpsonD. Possible toxicity of herbal remedies. Scot Med J.1998;43:7–15.
17.
RidkerPMOhkumaSMcDermottWVTreyCHuxtableRJ. Hepatic veno-occlusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. Gastroenterology.1988;88:1050–1054.
18.
VallaDBenhamouJP. Drug-induced vascular and sinusoidal lesions of the liver. Clin Gastroenterol.1988;2:481–500.
19.
HuxtableRJ. New aspects of the toxicology and pharmacology of pyrrolizidine alkaloids. Mol Pharmacol.1979;10:159–167.
20.
SteenkampVStewartMZuckermanM. Clinical and analytical aspects of pyrrolizidine alkaloid poisoning caused by South African traditional medicines. Ther Drug Monit.2000;22:302–306.
21.
ClarkF. Chaparral-induced toxic hepatitis: California and Texas, 1992. MMWR Morb Mortal Wkly Rep.1992;41:812–814.
22.
GordonDWRosenthalGHartJSirotaRBakerAL. Chaparral ingestion: The broadening spectrum of liver injury caused by herbal medications. JAMA.1995;273:489–490.
LarreyDVialTPauwelsA. Hepatitis after Germander (Teucrium chamaedrys) administration: Another instance of herbal medicine hepatotoxicity. Ann Int Med.1992;117:129–132.
25.
LarreyDPageauxGP. Hepatotoxicity of herbal remedies and mushrooms. Semin Liver Dis.1995;15:183–188.
26.
GruenwaldJBrendlerTJaenickeC, eds. Physician Desk Reference for Herbal Medicines.Montvale, NJ: Medical Economics Company; 2000.
27.
NadirAAgrawalSKingPDMarshallJB. Acute hepatitis associated with the use of a Chinese herbal product, Mahuang. Am J Gastroenterol.1996;91:1436–1438.
28.
BorumML. Fulminant exacerbation of autoimmune hepatitis after the use of Ma huang. Am J Gastroenterol.2001;96: 1654–1655.
29.
WoolfGMPetrovicLMRojterSE. Acute hepatitis associated with the Chinese herbal product Jin Bu Huan. Ann Int Med.1994;121:729–735.
30.
HorowitzRSFeldhausKDartRC. The clinical spectrum of Jin Bu Huan toxicity. Arch Intern Med.1996;156:899–903.
31.
PicciottoACampoNBrizzolaraR. Chronic hepatitis induced by Jin Bu Huan. J Hepatol.1998;28:165–167.
32.
BenningerJSchneiderHTSchuppanDKirchnerTHahnEG. Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology.1999;117:1234–1237.
33.
NadirAReddyDVan ThielDH. Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: Case report and review of herbal hepatotoxicity. Am J Gastroenterol.2000;95:3634–3637.
34.
YadhuSN. Kava Toxicity.New York, NY: Jobson Publishing; 2003.
De SmetP. Drug therapy: Herbal remedies. N Engl J Med.2002;347:2046–2056.
37.
BaroneGWGurleyBJKetelBLAbul-EzzSR. Herbal supplements: A potential for drug interations in transplant recipients. Transplantation.2001;71:239–241.
38.
MaiIStormerEBauerSKrugerHBuddeKRootsI. Impact of St John's Wort treatment on the pharmacokinetics of tacrolimus and mycophenolate acid in renal transplant patients. Nephrol Dial Transplant.2003;18:819–822.
39.
ChitturiSFarrellGC. Herbal hepatotoxicity: An expanding but poorly defined problem. J Gastroenterol Hepatol.2000;10:1093–1099.
40.
Satia-AboutaJKrsitalARPattersonRELittmanAJStrattonKLWhiteE. Dietary supplement use and medical conditions: The VITAL study. Am J Prev Med. January 2003;24:43–51.
41.
AnsaniNTCilibertoNCFreedyT. Hospital policies regarding herbal medicines. Am J Health Syst Pharm.2003;60:367–370.
